You have had all the tests. Your hormone levels look fine. Your partner's results came back normal. Your doctor has no clear answer — and yet, month after month, pregnancy isn't happening. If this sounds familiar, you are not alone. "Unexplained infertility" accounts for a significant portion of fertility diagnoses, and for many of the women who receive it, the label feels like a dead end.

But unexplained does not mean untreatable. Increasingly, research points to chronic low-grade inflammation as a silent driver of infertility — one that rarely shows up on a standard fertility workup, but can profoundly undermine conception and implantation. Understanding the inflammation-fertility connection may be one of the most important — and most overlooked — pieces of your fertility picture. WHAT IS CHRONIC LOW-GRADE INFLAMMATION?

Inflammation is not inherently harmful. In fact, a carefully calibrated inflammatory response is essential for fertility. Research published in Reproduction (Cambridge) confirms that both the implantation process and early pregnancy depend on precise immune signaling — too little inflammatory response and the endometrium cannot prepare to receive an embryo; too much, and the uterine environment becomes hostile to implantation.

The problem arises when inflammation becomes chronic and systemic — a low-level, persistent state of immune activation that does not resolve the way acute inflammation does. Unlike the inflammation you feel after a sprained ankle, chronic low-grade inflammation produces no obvious symptoms. It simmers quietly in the background, often for years, silently disrupting hormonal balance, immune regulation, and the delicate conditions required for conception.

How Inflammation Disrupts Fertility

Chronic inflammation can interfere with fertility through several overlapping pathways:

Disrupting the endometrial environment: The uterine lining is an immunologically active tissue. Research in the American Journal of Reproductive Immunology has shown that dysregulation of endometrial immune cells — including natural killer cells, macrophages, and T cells — is directly associated with implantation failure, even when embryo quality is not in question. When the immune microenvironment is out of balance, the window of implantation can be disrupted or narrowed, making successful embryo attachment less likely.

Chronic endometritis: One of the most underdiagnosed contributors to unexplained infertility is chronic endometritis (CE) — a low-grade bacterial inflammation of the uterine lining. Research published in the International Journal of Fertility and Sterility found that CE is more prevalent in infertile patients and that effective treatment significantly improves pregnancy and live birth rates in women with recurrent implantation failure and unexplained pregnancy loss. Because CE is typically asymptomatic and does not show up on standard ultrasound, it is frequently missed in conventional fertility evaluations.

Endometriosis and hidden inflammation: Even when endometriosis has not been formally diagnosed, sub-clinical endometrial inflammation may be at play. Research published in the Journal of the Turkish-German Gynecological Association highlights how endometriosis-related inflammation creates progesterone resistance and aberrant decidualization — a process that impairs the uterine lining's ability to support an embryo.

Inflammatory markers and IVF outcomes: Elevated C-reactive protein (CRP), a well-established systemic marker of inflammation, has been studied in the context of IVF outcomes. A review in the Journal of Assisted Reproduction and Genetics found that systemic inflammatory states during fertility treatment cycles are associated with altered endometrial conditions — underscoring that what is happening throughout the body can directly affect the uterine environment.

What Drives Chronic Inflammation?

This is where integrative and naturopathic medicine has a meaningful role to play — because conventional reproductive medicine rarely investigates the root causes of inflammation. Common drivers include:

Diet and blood sugar dysregulation: A diet high in refined carbohydrates, processed foods, and industrial seed oils promotes a pro-inflammatory state. Research published in Fertility and Sterility has examined the role of chronic low-grade inflammation in reproductive sequelae associated with conditions like PCOS and obesity, noting that dietary patterns significantly influence the inflammatory environment affecting reproductive outcomes. Blood sugar instability — even without a diabetes diagnosis — drives ongoing cytokine production that disrupts hormonal signaling.

Gut health and intestinal permeability: The gut is the largest immune organ in the body. When intestinal barrier integrity is compromised — sometimes called "leaky gut" — bacterial endotoxins can enter systemic circulation and trigger a persistent inflammatory response. Research in the American Journal of Reproductive Immunology has modeled how bacterial-derived lipopolysaccharide (LPS) disrupts implantation and decidualization, reducing implantation sites and altering cytokine expression in the uterus.

Chronic stress and cortisol dysregulation: Psychological and physiological stress activates the HPA axis and promotes pro-inflammatory cytokine production. Prolonged stress also suppresses immune tolerance mechanisms needed for successful implantation, creating a biochemical environment that works against pregnancy.

Environmental toxin burden: Persistent exposure to endocrine-disrupting chemicals — found in plastics, pesticides, personal care products, and household cleaning agents — promotes inflammation and interferes with hormonal signaling relevant to ovulation, implantation, and early pregnancy.

Subclinical thyroid dysfunction: Even thyroid values within the "normal" reference range can be suboptimal for fertility. Thyroid dysregulation and associated autoimmune inflammation are frequently missed contributors to unexplained infertility and early pregnancy loss.

THE NATUROPATHIC APPROACH TO INFLAMMATION AND FERTILITY Identifying and addressing inflammatory contributors to infertility is where naturopathic medicine excels. A thorough integrative evaluation may include:

- Advanced inflammatory marker testing, including hsCRP, homocysteine, and ferritin - Comprehensive thyroid assessment, including TSH, free T3, free T4, and thyroid antibodies - Gut health evaluation and microbiome support - Vaginal health evaluation and microbiome support - Nutritional analysis and an anti-inflammatory dietary protocol tailored to your physiology - Assessment for chronic endometritis or subclinical endometrial immune dysregulation - Environmental toxin review and targeted detoxification support - Stress physiology assessment and nervous system regulation strategies

The goal is not to add more interventions to an already overwhelming fertility journey. It is to identify what is actually driving your infertility — and address it at the root.

Unexplained infertility is rarely truly unexplained. More often, it reflects the limits of what a conventional workup is designed to find. Chronic low-grade inflammation is systemic, multifactorial, and deeply responsive to the kind of individualized, whole-body care that naturopathic medicine is uniquely positioned to provide.

Begin Your Journey

The fertility journey is rarely a straight line — but every path forward begins with a single step. At Origins Integrative Health, our approach to fertility care is as individual as your story. Whether you are just beginning to explore your options or have been navigating infertility for years, we are here to offer thoughtful, evidence-informed care that honors where you are and supports where you want to go.

Take the first step — schedule a fertility consultation with Dr. Laura Clevenger at Origins Integrative Health in Portland, Oregon.

Book a visit with Dr. Laura here or call the clinic at 503-314-2176

References

1. Genest G, Banjar S, Almasri W, et al. Immunomodulation for unexplained recurrent implantation failure: where are we now? Reproduction (Cambridge). 2023;165(2):R39–R60. https://doi.org/10.1530/REP-22-0150

2. Puente E, Alonso L, Lagana AS, Ghezzi F, Casarin J, Carugno J. Chronic endometritis: old problem, novel insights and future challenges. International Journal of Fertility and Sterility. 2020;13(4):250–256. https://doi.org/10.22074/ijfs.2020.5779

3. La Marca A, Gaia G, Mignini Renzini M, Alboni C, Mastellari E. Hysteroscopic findings in chronic endometritis. Minerva Obstetrics and Gynecology. 2021;73(6):790–805. https://doi.org/10.23736/S2724-606X.21.04970-8

4. Nezhat C, Agarwal S, Lee DA, Tavallaee M. Can we accurately diagnose endometriosis without a diagnostic laparoscopy? Journal of the Turkish-German Gynecological Association. 2022;23(2):117–119. https://doi.org/10.4274/jtgga.galenos.2022.2022-2-2

5. Diba-Bagtash F, Farshbaf-Khalili A, Ghasemzadeh A, et al. Maternal C-reactive protein and in vitro fertilization (IVF) cycles. Journal of Assisted Reproduction and Genetics. 2020;37(11):2635–2641. https://doi.org/10.1007/s10815-020-01924-1

6. Riley JK, Jungheim ES. Is there a role for diet in ameliorating the reproductive sequelae associated with chronic low-grade inflammation in polycystic ovary syndrome and obesity? Fertility and Sterility. 2016;106(3):520–527. https://doi.org/10.1016/j.fertnstert.2016.07.1069

7. Moustafa S, Joseph DN, Taylor RN, Whirledge S. New models of lipopolysaccharide-induced implantation loss reveal insights into the inflammatory response. American Journal of Reproductive Immunology. 2019;81(2):e13082. https://doi.org/10.1111/aji.13082

8. Cheng Y, Wang H, Shang J, et al. Transcriptomic analysis of mid-secretory endometrium reveals essential immune factors associated with pregnancy after single euploid blastocyst transfer. American Journal of Reproductive Immunology. 2022;89(3):e13672. https://doi.org/10.1111/aji.13672

9. Sheikhansari G, Pourmoghadam Z, Danaii S, Mehdizadeh A, Yousefi M. Etiology and management of recurrent implantation failure: a focus on intra-uterine PBMC-therapy for RIF. Journal of Reproductive Immunology. 2020;139:103121. https://doi.org/10.1016/j.jri.2020.103121